IP
IndiaPulse

COLPAL

Mid Cap

Colgate Palmolive (India) Limited

Consumer

Colgate-Palmolive (India) Limited is a leading oral care company in India, focused on driving consumption in the toothpaste category, accelerating premiumization, and growing its toothbrush and personal care businesses. It emphasizes oral health education and strong brand partnerships.

₹2,021.9
+16.40 · +0.82%
Quote09 Jun, 10:02 am
Fundamentals08 Jun 2026 · screener
Score08 Jun, 11:00 pm · v4.2-nightly
Tags02 May 2026
Data confidence
Fresh enough for analysis
Investor decision lenses

One read, four checks

75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.

Mixed fundamentals, management trust is supportive, price trend is neutral, and recent execution is weak.

Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
FAIR VALUE
49

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Trust
Healthy Trust
81

low confidence · 0/0 claims checked

Technical
Neutral
46

Timing lens: price trend and sector relative strength.

Result consistency
weak
49

Rolling lens: recent quarterly delivery, not the latest single-result score.

Latest result

Quarter ended 31 Mar 2026

Bad · 0/100

PAT -1% YoY · margin compression · Rev +9% YoY · +7% QoQ

Filed 22 May 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹1,595 Cr+9.0%+7.3%
EBITDA₹510 Cr+2.4%+15.4%
Operating margin32.0%-200 bps+200 bps
PAT₹353 Cr-0.6%+8.9%
PAT margin22.1%-214 bps+33 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Business and thesis

Where growth can come from, and what can break the case

Thesis intactReviewed 2026-06-03T19:10:43.628Z
Management commentary snapshot

Q4 FY26 domestic net sales grew 9.2% YoY to Rs. 1,583 crores, driven by broad-based growth across Core and Premium portfolios, with resilient gross margins at 69.6% and EBITDA margins over 32%.

Management reports significant Q4 acceleration in domestic sales, driven by product superiority, premiumization, and increased ad spend elasticity. While full-year growth was flat, H2 showed a 5%+ step-up. Sustaining volume-led growth and managing competitive intensity are key.

Growth engines

Core Brand Superiority

Relaunched Colgate Strong Teeth with our best ever formulation, powered by arginine plus calcium boost, 8.5x more effective at re-mineralizing than competition.

Accelerated Oral Care Premiumization

Colgate Total (Dual Zinc and Arginine) linked to 'Peak Performance'; Visible White Purple growing 4x faster than the overall Toothpaste category.

Toothbrush Category Expansion

Significant growth opportunity in India, playing across value, mid-tier, Premium, and kids segments, with new brushes and a Rs. 10 brush.

Personal Care (Palmolive)

Foaming Hand Washes growing double-digit; Body Wash 'Moments Range' innovation; opportunity for a more digital-first approach.

Tailwinds

Increased Ad Spend Elasticity

Significant elasticity on advertising on the Premium portfolio and overall increased brand investments.

E-commerce Channel Growth

E-commerce as a channel is growth-accretive, margin-accretive, share-accretive, premiumization-accretive for us.

Oral Health Awareness Initiatives

Programs like 'Bright Smiles, Bright Future', government partnerships, and 'Free Dental Checkup' via QR codes are driving consumption.

Product and Packaging Superiority

Products are now 100% superior to competition across the core, toothbrushes, and packaging, underpinned by best-in-class science.

Headwinds

Commodity and Currency Challenges

Despite all the headwinds of commodity and currency, we continue to deliver very good margins.

GST Inverted Duty Structure (IDS) Impact

EBITDA margin for the full year includes an 80-bps impact from the GST IDS impact. For the quarter, 160 bps.

Competitive Promotional Intensity

We are not seeing any let up in promotional intensity. The market continues to be quite competitive.

Risk radar

Sustaining Volume Growth

Our endeavor is to deliver a balanced growth between volume and pricing, not relying on pricing as much as we have probably done in the past.

Competitive Product Imitation

Competitors launch an extremely similar kind of product, which looks almost like a Xerox copy in terms of the product and maybe even the packaging (Visible White Purple).

Input Cost Inflation

There are some headwinds in terms of commodities and also the currency coming through.

Management accountability

What management said, and what results must prove

Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.

Analyst reading lens
Compare BOTH

Q4 results are presented YoY, showing significant acceleration. However, the full year was flat, and management highlights H2 vs H1 growth, indicating sequential momentum is also crucial for assessing recovery.

Sector KPIs management disclosed

Net Sales Growth (Q4 FY26)

Domestic growth now at 9.2% YoY.

Gross Margin (Q4 FY26)

Gross margins continue to be strong at 69.6%.

EBITDA Margin (Q4 FY26)

EBITDA margins continue to be absolutely best in class at a shade over 32%.

Brand Investments (Q4 FY26)

Brand investments, just a shade under Rs. 200 crores, represents a significant step up from the same quarter the previous year at 10% increased investment.

Management forward view

Renewed Optimism for CY26

As we enter the Calendar Year 2026, we feel a renewed sense of optimism and confidence in terms of what this business can deliver.

Focus on Balanced Growth

Our endeavor is to deliver a balanced growth between volume and pricing. So, similar to what we saw in Q4, that's the kind of volume we are looking at going forward.

Continued Investment in Brands

We are seeing significant elasticity on stepped up investment and we intend to continue to step up investment to further drive growth.

Gross Margin Resilience

Gross margins would stay in the range is what I wanted to communicate, despite the headwinds we are seeing and the currency challenges.

Thesis monitor

Numbers and claims to verify in the next filings

CheckpointCurrent evidenceWhat to verify next
Volume GrowthBalanced with pricing in Q4 FY26.Sustained volume growth, not just base effect, and contribution from new households.
Premiumization ContributionIncreased 35% over the past two years.Continued acceleration in growth rate and contribution to overall business.
Advertising Spend & Elasticity10% increase in Q4 FY26, good elasticity observed.Continued step-up in ad spend and sustained positive elasticity on growth.
GST IDS Impact Mitigation80-160 bps impact on EBITDA margins.Progress on efficiency measures, government representations, and supplier efforts to mitigate impact.

Verification checkpoints are IndiaPulse research interpretation, not investment advice.

Technical timing lens

Trend score and candlestick chart

46Neutral

label neutral

Stock trend: 46
Sector RS: 45
Sector 3M: -0.7% vs Nifty +0.1%

Technical chart

COLPALweekly · 1Y-14.7%
Latest close ₹2023.40 on 2026-06-09
Bar
+1.9%
RSI
44
MACD hist
-6.66
52W pos
35%
Hover for OHLC, volume, and indicators. Use range buttons above the chart to zoom.
₹1.7k₹1.9k₹2.1k₹2.3k₹2.5k52H52L2025-062025-092025-122026-03Vol2025-062025-102026-012026-052026-06
Up bar
Down bar
Volume
Result date
SMA 50
RSI(14)

Technical trend read

Neutral

Trend is undirectional — long-term trend unclear. RSI 44.

  • SMA20 roughly flat — short-term momentum stalled.
  • RSI(14) at 44 — rising, no extreme reading.
  • MACD below signal but histogram contracting — bearish momentum easing.
  • 18% off 52W high · 14% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Deep research

Valuation, score drivers, trust methodology, financials, and peers

Use these sections after reviewing the decision summary, latest result, thesis, management accountability, and technical timing above.

49U-SCORE
Premium Compounder

Fundamental score breakdown

FAIR VALUE
Valuation0/30
Growth7/25
Quality20/20
Balance Sheet11/15
Cash Flow6/10
Piotroski
8/9 (+5)
Penalties
0
Raw sum
49

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

49/100 · FAIR VALUE

Positive drivers

  • Piotroski is strong at 8/9.
  • Quality contributes 20/20 to the score.
  • Balance sheet contributes 11/15 to the score.

Main drags

  • Fair-value margin of safety is negative at -1080.7%.
  • Valuation is weaker at 0/30; verify the latest quarterly trend.
  • Growth is weaker at 7/25; verify the latest quarterly trend.
Sector valuation model

Consumer valuation: PE/PEG and brand-quality premium

Consumer franchises can deserve higher multiples, but only when growth quality supports them.

Consumer PE/PEG
Primary lens
PE and PEG relative to growth, ROE, margins, and brand strength.
Secondary checks
Volume growth, pricing power, distribution, same-store or category growth.
Main risk check
Premium valuation needs durable growth and margin resilience.
PE
126.0
PB
165.8
EV/EBITDA
117.3
ROE
158.0%
ROCE
179.0%
FCF Yield
0.8%
Debt/Equity
0.0
MoS
-1080.7%
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 08 Jun 2026
v4.2-nightly
Final score
49
Previous: 49
Verdict
FAIR VALUE
Previous: FAIR VALUE
Margin of safety
-1080.7%
Previous: -1066.7%

Score history

12 stored score snapshots. Latest stored move: +0 points.

08 Jun 2026
v4.2-nightly
51
51
55
55
49
49
51
49
55
55
49
49

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Trust Score
81Healthy Trust · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Healthy Trust: Claim history is still being built. It ranks around the 93rd percentile of the scored universe and 94th percentile within Consumer. Main check: results consistency is weak at 49/100.

High Trust Lite: Promoter pledge is zero. Key concern: 1/4 latest quarters had positive YoY PAT growth.

Computed 08 Jun 2026
management-trust-v1
68 docs indexed · 21 concall links
Score band
Healthy Trust

Generally investable credibility. Look for weak sub-scores before increasing position size.

Relative rank
93rd percentile

overall median 67 · Consumer: 94th pctile, median 67 · Mid: 74th pctile, median 76

Evidence depth
Financial-only

68 documents indexed, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Healthy Trust · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Can support position sizing if valuation and trend also agree.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
78
strong · holding, pledge, alignment
Cash flow
77
strong · profit to cash conversion
Balance sheet
96
strong · leverage and solvency
Discipline
98
strong · capital discipline
Results
49
watch · quarterly consistency

Trust positives

  • Promoter pledge is zero.
  • FCF yield is positive at 0.8%.
  • 5 years of positive FCF.
  • Debt/equity is 0.02.

Trust risks

  • 1/4 latest quarters had positive YoY PAT growth.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Intrinsic value

Graham Number
₹65.92
-2967.3% MoS
DCF Fair PE
10.7
DCF Fair Value
₹171.25
-1080.7% MoS
PEG
26.25

Fundamentals

Valuation

P/E
126.00
P/B
165.79
EV/EBITDA
117.32
Market Cap
54551.00Cr

Profitability

ROE
158.00%
ROCE
179.00%
ROA
49.27%
Dividend Y
2.54%

Growth (CAGR)

Revenue 5Y
3.00%
EPS 5Y
3.00%
Revenue 3Y
15.00%
EPS 3Y
33.00%

Balance Sheet

Debt/Equity
0.02
Interest Coverage
217.00×
Altman Z
10.17
Book Value
12.10

Cash Flow

FCF Yield
0.79%
FCF Positive Y
5/5
OCF
404.00 Cr
EPS TTM
15.96

Shareholding

Promoter Hold
51.00%
Promoter Pledge
0.00%
Momentum 52W
31%

Financial History

Updated 9/6/2026

Revenue

₹ Cr
No data

Net Profit

₹ Cr
No data

Return on Equity

%
No data
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.